Download - WHOCC
Download - WHOCC
Download - WHOCC
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
QC09D<br />
QC09DA<br />
QC09DX<br />
ANGIOTENSIN II ANTAGONISTS, COMBINATIONS<br />
Angiotensin II antagonists and diuretics<br />
Angiotensin II antagonists, other combinations<br />
QC09X<br />
QC09XA<br />
OTHER AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM<br />
Renin-inhibitors<br />
Fixed combinations of aliskiren and valsartan are classified in QC09DX<br />
QC10<br />
LIPID MODIFYING AGENTS<br />
Agents for the treatment of hyperlipidemia (or hyperlipoproteinemia) are<br />
classified in this group.<br />
QC10A<br />
QC10AA<br />
QC10AB<br />
QC10AC<br />
QC10AD<br />
LIPID MODIFYING AGENTS, PLAIN<br />
HMG CoA reductase inhibitors<br />
Fibrates<br />
Bile acid sequestrants<br />
Nicotinic acid and derivatives<br />
Combinations of nicotinic acid and laropiprant are classified in QC10AD52.<br />
QC10AX<br />
Other lipid modifying agents<br />
QC10B<br />
QC10BA<br />
QC10BX<br />
LIPID MODIFYING AGENTS, COMBINATIONS<br />
HMG CoA reductase inhibitors in combination with other lipid modifying agents<br />
HMG CoA reductase inhibitors, other combinations<br />
58
Change language